Two industries tell the story of India’s rise as a global sourcing destination and the data behind both is stronger than most people realize.
India, the pharmacy of the world
India is the largest vaccine manufacturer globally by volume, accounting for over 60% of the world’s vaccine production, and supplies roughly 60% of UNICEF’s global vaccine demand. Its dominance goes deeper by disease: India meets close to 90% of the WHO’s global measles vaccine demand and 40-70% of global DPT and BCG vaccine demand.
On generics, India manufactures approximately 20% of the world’s generic medicines by volume and ranks third globally in pharmaceutical production by volume. The sector, valued at around $60 billion domestically in 2025, is projected to reach $130 billion by 2030 with pharmaceutical exports reaching $30.5 billion in FY 2024-25, shipped to 191 countries, and roughly 50% of those exports going to highly regulated markets like the US and EU.
India, the rising manufacturer
On the manufacturing side, India ranks 5th globally with manufacturing output of approximately $490 billion in 2024, representing about 2.91% of global manufacturing production placing it just behind China, the United States, Japan and Germany, and ahead of South Korea and Mexico. India’s manufacturing base spans textiles, automotive, engineering goods and pharmaceuticals, and it’s currently recognized as the fastest-growing large manufacturing economy in the world, with its manufacturing market projected to nearly triple by 2035.
Why global buyers are paying attention now
Global supply chains are actively diversifying away from single-country dependence, and India is capturing a growing share of that shift backed by government programs like the Production Linked Incentive (PLI) scheme and Make in India, which are attracting investment across electronics, pharmaceuticals and renewable energy. On the pharma side, the newly proposed Biopharma SHAKTI initiative, with a ₹10,000 crore outlay, is designed to move India beyond generics into biologics and biosimilars signaling the next phase of growth international buyers should watch.
The real bottleneck isn’t capacity it’s visibility
India’s manufacturing and pharmaceutical capabilities are well-documented at the macro level. What’s harder for international buyers is finding the right manufacturer or exporter for their specific requirement verified, compliant, and genuinely ready to deliver at the volumes and standards they need.
Where GTEC fits in
That’s precisely the layer GTEC operates in connecting international buyers with verified Indian manufacturers and pharmaceutical exporters across 12+ industry sectors, backed by on-the-ground presence in the Indian market.
India’s pharmaceutical and manufacturing sectors aren’t emerging opportunities anymore they’re established global supply pillars. The advantage now belongs to the businesses that can find the right verified partner inside them fastest.
